# Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Study · id `cardio:ct-nct03006770` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03006770](<https://clinicaltrials.gov/study/NCT03006770>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03006770

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 213 participants.

## Technical summary

Registry record NCT03006770. Randomized; double masking; primary purpose treatment. Start 2017-05-22 (actual); primary completion 2021-03-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 213 participants (enrolled count; ClinicalTrials.gov record NCT03006770, source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)
- Started: 2017-05-22 (actual) (ClinicalTrials.gov record NCT03006770, source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)
- Primary completion: 2021-03-03 (actual) (ClinicalTrials.gov record NCT03006770, source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)
- Completion: 2022-04-20 (actual) (ClinicalTrials.gov record NCT03006770, source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)
- Countries: United States; Bulgaria; Czechia; Germany; Hungary; Israel; North Macedonia; Poland; United Kingdom (ClinicalTrials.gov record NCT03006770, source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03006770-2024-08-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
- Condition: Critical Limb Ischemia (CLI)
- Intervention (Biological): PLX-PAD
- Intervention (Biological): Placebo
- Lead sponsor: Pluristem Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial (`cardio:pubmed-38294084`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 546f28b55fe629416d2f76b7c1ef90a145b85ec13e6ad95239af260b4ae31ca7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
